{
    "2020-09-09": [
        [
            {
                "time": "2020-09-09",
                "original_text": "9月9日北向资金成交活跃股名单",
                "features": {
                    "keywords": [
                        "北向资金",
                        "成交活跃",
                        "股名单"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-08",
                "original_text": "A股融资融券日报：两融余额减少8.54亿元（9月8日）",
                "features": {
                    "keywords": [
                        "两融余额",
                        "减少",
                        "A股"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "创新药的估值泡沫，啥时候破？",
                "features": {
                    "keywords": [
                        "创新药",
                        "估值泡沫"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "医药生物行业2020半年报业绩回顾：疫情冲击明显 子板块业绩分化",
                "features": {
                    "keywords": [
                        "医药生物",
                        "半年报",
                        "疫情",
                        "业绩分化"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "天风证券：创新药是未来医药发展最核心的方向之一 建议关注恒瑞医药等",
                "features": {
                    "keywords": [
                        "天风证券",
                        "创新药",
                        "恒瑞医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "美股三大指数集体大跌两股不惧压力强势爆发 连续下跌",
                "features": {
                    "keywords": [
                        "美股",
                        "大跌",
                        "强势爆发"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "【医药】2020中报总结兼9月月报：医药二季度表现亮眼，业绩环比改善明显",
                "features": {
                    "keywords": [
                        "医药",
                        "中报",
                        "业绩环比改善"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "医保目录调整在即：130余新药或谈判纳入，新冠用药是重点",
                "features": {
                    "keywords": [
                        "医保目录",
                        "新药",
                        "新冠用药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}